Recent advances in novel drug delivery systems and approaches for management of breast cancer: A comprehensive review
Breast Cancer (BC) is a carcinoma of breast tissues, the major recurrent cancer in women
and also the foremost cause of death with approximate 5 million annual deaths worldwide …
and also the foremost cause of death with approximate 5 million annual deaths worldwide …
Modern radiation therapy and cardiac outcomes in breast cancer
IJ Boero, AJ Paravati, DP Triplett, L Hwang… - International Journal of …, 2016 - Elsevier
Purpose Adjuvant radiation therapy, which has proven benefit against breast cancer, has
historically been associated with an increased incidence of ischemic heart disease. Modern …
historically been associated with an increased incidence of ischemic heart disease. Modern …
The assisi think tank meeting and survey of post MAstectomy radiation therapy after breast reconstruction: the ATTM-SMART report
C Aristei, O Kaidar-Person, L Tagliaferri… - European Journal of …, 2018 - Elsevier
Purpose To describe the current European practise on post-mastectomy radiation therapy
(PMRT) in relation to breast reconstruction. Methods A 21-item questionnaire was distributed …
(PMRT) in relation to breast reconstruction. Methods A 21-item questionnaire was distributed …
Challenges facing radiation oncologists in the management of older cancer patients: Consensus of the International Geriatric Radiotherapy Group
T Popescu, U Karlsson, V Vinh-Hung, L Trigo, J Thariat… - Cancers, 2019 - mdpi.com
The management of older cancer patients remains difficult because of data paucity.
Radiation oncologists need to identify potential issues which could affect treatment of those …
Radiation oncologists need to identify potential issues which could affect treatment of those …
[HTML][HTML] Hypofractionated radiation therapy for breast cancer: Preferences amongst radiation oncologists in Europe–Results from an international survey
I Ratosa, ME Chirilă, M Steinacher, E Kozma… - Radiotherapy and …, 2021 - Elsevier
Background and purpose We aimed to assess the prescription preference about
hypofractionated radiation therapy (HFRT) for breast cancer (BC) patients amongst radiation …
hypofractionated radiation therapy (HFRT) for breast cancer (BC) patients amongst radiation …
Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results
F De Rose, A Fogliata, D Franceschini, P Navarria… - Radiation …, 2016 - Springer
Background To report toxicity and early clinical outcomes of hypofractionated simultaneous
integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant …
integrated boost (SIB) approach with Volumetric Modulated Arc Therapy (VMAT) as adjuvant …
Trace element concentrations in breast cancer patients
Alterations in the circulating levels of trace elements have been observed in breast cancer
(BC) patients. However, the relationships between these alterations and the metabolic and …
(BC) patients. However, the relationships between these alterations and the metabolic and …
[HTML][HTML] Preliminary Metabolomics Study Suggests Favorable Metabolic Changes in the Plasma of Breast Cancer Patients after Surgery and Adjuvant Treatment
A Jiménez-Franco, JM Jiménez-Aguilar… - Biomedicines, 2024 - mdpi.com
Background/Objectives: The management of early breast cancer (BC) includes surgery,
followed by adjuvant radiotherapy, chemotherapy, hormone therapy, or immunotherapy …
followed by adjuvant radiotherapy, chemotherapy, hormone therapy, or immunotherapy …
Understanding variations in the use of hypofractionated radiotherapy and its specific indications for breast cancer: A mixed-methods study
Background and purpose Radiation oncology guidelines favour hypofractionated whole-
breast radiotherapy (HWBRT) over more conventional schemes in the conservative …
breast radiotherapy (HWBRT) over more conventional schemes in the conservative …
Effect of radiotherapy on activity and concentration of serum paraoxonase-1 in breast cancer patients
Paraoxonase-1 (PON1) is an intra-cellular antioxidant enzyme found also in the circulation
associated with high-density lipoproteins. The activity of this enzyme has been shown to be …
associated with high-density lipoproteins. The activity of this enzyme has been shown to be …